When nafamostat mesilate (SK Chemicals Life Science Biz., Seoul, Korea licensed by Torii Pharmaceutical Co., LTD, Tokyo, Japan) was used for anticoagulation during the ECMO, the maintenance dose was held at 0.4–1.5 mg/kg/h to maintain a partial thromboplastin time of 60–80 s [ 12 ].
Source: wiktionary